Limited benefit to genetically dystrophic chickens from a synthetic proteinase inhibitor: Ep475
- 30 June 1983
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 60 (1) , 55-66
- https://doi.org/10.1016/0022-510x(83)90126-0
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Drug evaluation in muscular dystrophy of the chickenMuscle & Nerve, 1982
- Loss of Strength and Functional Decline in Duchenne's DystrophyArchives of Neurology, 1981
- Clinical trial in duchenne dystrophy. I. The design of the protocolMuscle & Nerve, 1981
- Phenytoin, methysergide, and penicillamine in hereditary muscular dystrophy of the chickenExperimental Neurology, 1981
- Animal models of muscle diseases Part I: Avian dystrophyMuscle & Nerve, 1980
- Ca2+ binding, ATP-dependent Ca2+ transport, and total tissue Ca2+ in embryonic and adult avian dystrophic pectoralisThe Journal of Membrane Biology, 1978
- Treatment of Mouse Muscular Dystrophy with the Protease Inhibitor PepstatinJournal of Neuropathology and Experimental Neurology, 1978
- Intracellular calcium accumulation in Duchenne dystrophy and other myopathiesNeurology, 1978
- Therapeutic Trials in Muscular DystrophyArchives of Neurology, 1977
- Ca2+-SPECIFIC REMOVAL OF Z LINES FROM RABBIT SKELETAL MUSCLEThe Journal of cell biology, 1972